Literature DB >> 9563995

North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.

M Eccles1, N Freemantle, J Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9563995      PMCID： PMC1113074          DOI： 10.1136/bmj.316.7141.1369

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  42 in total

1.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.

Authors: 
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

2.  Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study.

Authors:  W D Bussmann; H Störger; D Hadler; N Reifart; W Fassbinder; E Jungmann; M Kaltenbach
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

3.  Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1995-06       Impact factor: 29.983

4.  Evaluation of the safety of enalapril in the treatment of heart failure in the very old.

Authors:  C J O'Neill; S G Bowes; C M Sullens; J P Royston; W B Hunt; M J Denham; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.

Authors:  B Magnani; C Magelli
Journal:  Postgrad Med J       Date:  1986       Impact factor: 2.401

6.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

7.  Enalapril in heart failure.

Authors:  M G Nicholls; H Ikram; E A Espiner; M W Webster; M A Fitzpatrick
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

8.  Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.

Authors:  J G Cleland; H J Dargie; S G Ball; G Gillen; G P Hodsman; J J Morton; B W East; I Robertson; I Ford; J I Robertson
Journal:  Br Heart J       Date:  1985-09

9.  A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1983-10       Impact factor: 24.094

10.  Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Authors:  H Drexler; U Banhardt; T Meinertz; H Wollschläger; M Lehmann; H Just
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690
View more
  22 in total

1.  Audit of use of ACE inhibitors and monitoring in general practice. Guidelines on monitoring, on their own, are not sufficient.

Authors:  N Freemantle; J Mason; M Eccles
Journal:  BMJ       Date:  1999-06-19

2.  Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice.

Authors:  N Freemantle; R Johnson; J Dennis; A Kennedy; M Marchment
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

Review 3.  Clinical guidelines: using clinical guidelines.

Authors:  G Feder; M Eccles; R Grol; C Griffiths; J Grimshaw
Journal:  BMJ       Date:  1999-03-13

4.  The evidence for beta blockers in heart failure.

Authors:  J G Cleland; J McGowan; A Clark; N Freemantle
Journal:  BMJ       Date:  1999-03-27

5.  Developing valid cost effectiveness guidelines: a methodological report from the north of England evidence based guideline development project.

Authors:  M Eccles; J Mason; N Freemantle
Journal:  Qual Health Care       Date:  2000-06

6.  The barriers to effective management of heart failure in general practice.

Authors:  J A Hickling; I Nazareth; S Rogers
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

7.  A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.

Authors:  Nick Freemantle; Irwin Nazareth; Martin Eccles; John Wood; Andrew Haines
Journal:  Br J Gen Pract       Date:  2002-04       Impact factor: 5.386

8.  Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.

Authors:  N Freemantle; J Mason
Journal:  BMJ       Date:  1999-05-29

9.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

10.  Methodology for constructing guidance.

Authors:  W S A Smellie; D I Finnigan; D Wilson; D Freedman; C A M McNulty; G Clark
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.